CADL
Candel Therapeutics, Inc. · Healthcare · Market cap $640.5M
Insiders sold $3.6M net in the last 90 days ·3 sellers, 0 buyers· 5 of 5 sales under Rule 10b5-1 plans· latest Form 4 filed Sep 11, 2026
Insider Buying
$3.0M
reported purchases (SEC code P)
Insider Selling
$3.6M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Latest filing
Sep 11, 2026
Tak Paul Peter
Candel Therapeutics, Inc. (CADL) has 5 SEC Form 4 filings (7 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Sep 11, 2026.
Inside the rolling window, 4 insiders at Candel Therapeutics, Inc. reported 1 open-market purchase totaling $3.0M and 5 open-market sales totaling $3.6M. Insiders have net sold $3.6M over the trailing 6 months. The most recent open-market filing is a sale of 220,866 shares by Chief Executive Officer Tak Paul Peter, dated Sep 10, 2026, worth $2.5M.
- Industry:Biotechnology
- CEO:Paul-Peter Tak
- Employees:55
- HQ:Needham, MA, US
- IPO:2021-07-27
| Source | |||||||
|---|---|---|---|---|---|---|---|
Tak Paul PeterFirst filing | Chief Executive Officer | Sale | 220,866 | $2.5M | Sep 11 | -20.6% | SEC ↗ |
Tak Paul PeterFirst filing | Chief Executive Officer | Sale | 59,379 | $621K | Sep 11 | -20.6% | SEC ↗ |
| Chief Technology Officer | Sale | 7,000 | $84K | Aug 19 | -38.0% | SEC ↗ | |
Tyagarajan SeshuFirst filing | Chief Technology Officer | Sale | 7,000 | $70K | Jul 1 | -15.3% | SEC ↗ |
Barone FrancescaFirst filing | Chief Scientific Officer | Sale | 23,447 | $236K | Jul 1 | -15.3% | SEC ↗ |
Manning Paul BFirst in 3 months | Director | Purchase | 550,458 | $3.0M | Feb 26 | +62.5% | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does CADL have?
Candel Therapeutics, Inc. (CADL) has 5 SEC Form 4 filings (7 transaction rows) in the rolling 365-day window, disclosed by 4 distinct insiders. Most recent filing: Sep 11, 2026.
When was the most recent SEC Form 4 filing for CADL?
The most recent Form 4 filing for CADL on Tracefour is dated Sep 11, 2026.
What is the net insider flow at CADL over the last 6 months?
Over the trailing 180 days, insiders at CADL have net sold $3.6M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at CADL in the current window?
Inside the rolling window, insiders at CADL bought $3.0M and sold $3.6M based on SEC Form 4 filings.
Can I get alerts for CADL insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Candel Therapeutics, Inc. (CADL). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Candel Therapeutics, Inc. is in the Healthcare sector.